NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,156,793 | -21.7% | 3,129,906 | +3.5% | 0.00% | 0.0% |
Q2 2023 | $76,850,685 | -33.2% | 3,023,237 | -5.0% | 0.00% | -33.3% |
Q1 2023 | $115,031,577 | -36.8% | 3,182,063 | -30.8% | 0.00% | -50.0% |
Q4 2022 | $182,023,541 | -19.8% | 4,596,554 | -5.6% | 0.01% | -25.0% |
Q3 2022 | $227,012,000 | +7.0% | 4,871,522 | +0.6% | 0.01% | +14.3% |
Q2 2022 | $212,207,000 | -37.8% | 4,841,616 | +2.6% | 0.01% | -22.2% |
Q1 2022 | $341,322,000 | +1.4% | 4,718,980 | +13.7% | 0.01% | 0.0% |
Q4 2021 | $336,460,000 | -27.9% | 4,150,231 | +3.5% | 0.01% | -30.8% |
Q3 2021 | $466,576,000 | -29.1% | 4,009,071 | +1.0% | 0.01% | -27.8% |
Q2 2021 | $657,800,000 | +22.5% | 3,967,669 | +3.1% | 0.02% | +12.5% |
Q1 2021 | $536,762,000 | -16.6% | 3,847,760 | +3.4% | 0.02% | -23.8% |
Q4 2020 | $643,965,000 | +32.8% | 3,720,187 | +6.8% | 0.02% | +16.7% |
Q3 2020 | $485,027,000 | +17.3% | 3,481,879 | +0.6% | 0.02% | +5.9% |
Q2 2020 | $413,575,000 | +39.1% | 3,461,749 | +16.4% | 0.02% | +13.3% |
Q1 2020 | $297,347,000 | -7.3% | 2,974,055 | +9.0% | 0.02% | +25.0% |
Q4 2019 | $320,629,000 | +38.9% | 2,727,823 | +1.6% | 0.01% | +20.0% |
Q3 2019 | $230,842,000 | +37.8% | 2,685,139 | +3.9% | 0.01% | +42.9% |
Q2 2019 | $167,491,000 | +4.9% | 2,583,530 | +1.2% | 0.01% | 0.0% |
Q1 2019 | $159,643,000 | +48.4% | 2,553,893 | -7.6% | 0.01% | +40.0% |
Q4 2018 | $107,545,000 | -30.5% | 2,765,396 | +1.9% | 0.01% | -28.6% |
Q3 2018 | $154,716,000 | -34.3% | 2,714,326 | -7.9% | 0.01% | -36.4% |
Q2 2018 | $235,328,000 | +1.2% | 2,947,118 | +9.9% | 0.01% | 0.0% |
Q1 2018 | $232,427,000 | +28.7% | 2,681,757 | +2.5% | 0.01% | +22.2% |
Q4 2017 | $180,662,000 | -20.0% | 2,616,753 | +5.2% | 0.01% | -18.2% |
Q3 2017 | $225,967,000 | +69.8% | 2,486,433 | +39.1% | 0.01% | +57.1% |
Q2 2017 | $133,073,000 | -9.8% | 1,787,896 | +13.5% | 0.01% | -12.5% |
Q1 2017 | $147,602,000 | +98301.3% | 1,575,240 | +76628.7% | 0.01% | – |
Q4 2016 | $150,000 | -42.1% | 2,053 | -17.4% | 0.00% | – |
Q3 2016 | $259,000 | +41.5% | 2,485 | -0.1% | 0.00% | – |
Q2 2016 | $183,000 | +200.0% | 2,487 | +130.1% | 0.00% | – |
Q1 2016 | $61,000 | +64.9% | 1,081 | +96.5% | 0.00% | – |
Q4 2015 | $37,000 | +131.2% | 550 | +60.8% | 0.00% | – |
Q3 2015 | $16,000 | -11.1% | 342 | 0.0% | 0.00% | – |
Q2 2015 | $18,000 | +200.0% | 342 | +167.2% | 0.00% | – |
Q1 2015 | $6,000 | – | 128 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |